Figure 3.

TEL-AML1 fusion as a minimal residual disease. Kaplan-Meier curve for the persistence of TEL-AML1 fusion as a minimal residual disease (MRD) as a predictor of overall cumulative survival.

Mosad et al. Journal of Hematology & Oncology 2008 1:17   doi:10.1186/1756-8722-1-17
Download authors' original image